DD273440A5 - Verfahren zur herstellung von 1,2 benzisoxazolen und 1,2-benziothiazolen - Google Patents

Verfahren zur herstellung von 1,2 benzisoxazolen und 1,2-benziothiazolen Download PDF

Info

Publication number
DD273440A5
DD273440A5 DD88317643A DD31764388A DD273440A5 DD 273440 A5 DD273440 A5 DD 273440A5 DD 88317643 A DD88317643 A DD 88317643A DD 31764388 A DD31764388 A DD 31764388A DD 273440 A5 DD273440 A5 DD 273440A5
Authority
DD
German Democratic Republic
Prior art keywords
lower alkyl
hydrogen
formula
compounds
compound
Prior art date
Application number
DD88317643A
Other languages
German (de)
English (en)
Inventor
Robert M Bowman
Original Assignee
���@����������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���@����������@��k�� filed Critical ���@����������@��k��
Publication of DD273440A5 publication Critical patent/DD273440A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD88317643A 1987-07-08 1988-07-06 Verfahren zur herstellung von 1,2 benzisoxazolen und 1,2-benziothiazolen DD273440A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/071,124 US4859691A (en) 1987-07-08 1987-07-08 Certain 1,2-benzisoxazole derivatives

Publications (1)

Publication Number Publication Date
DD273440A5 true DD273440A5 (de) 1989-11-15

Family

ID=22099383

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88317643A DD273440A5 (de) 1987-07-08 1988-07-06 Verfahren zur herstellung von 1,2 benzisoxazolen und 1,2-benziothiazolen

Country Status (21)

Country Link
US (1) US4859691A (el)
EP (1) EP0298921B1 (el)
JP (1) JPS6429376A (el)
KR (1) KR890002134A (el)
AT (1) ATE83776T1 (el)
AU (1) AU602594B2 (el)
DD (1) DD273440A5 (el)
DE (1) DE3876875D1 (el)
DK (1) DK379888A (el)
ES (1) ES2053802T3 (el)
FI (1) FI883218A (el)
GR (1) GR3007228T3 (el)
HU (1) HU206343B (el)
IL (1) IL86981A (el)
MX (1) MX12167A (el)
MY (1) MY103571A (el)
NO (1) NO170804C (el)
NZ (1) NZ225312A (el)
PT (1) PT87919B (el)
YU (1) YU131388A (el)
ZA (1) ZA884879B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957931A (en) * 1987-07-08 1990-09-18 Ciba-Geigy Corporation Certain 1,2-benzisoxazole and 1,2-benzisothiazole derivatives
JPH03258779A (ja) * 1990-03-06 1991-11-19 Mitsui Toatsu Chem Inc イミダゾール誘導体及び該イミダゾール誘導体を有効成分とする抗痙攣剤
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
DE4013723A1 (de) * 1990-04-28 1991-10-31 Basf Ag 5-(1,2,4-triazol-1-ylmethyl)-isoxazoline
TW200608978A (en) * 2004-05-28 2006-03-16 Speedel Experimenta Ag Organic compounds
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
WO2015094670A1 (en) * 2013-12-20 2015-06-25 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
GB201401198D0 (en) * 2014-01-24 2014-03-12 Bial Portela & Ca Sa Process for the syntheis of substituted urea compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545545B2 (el) * 1972-03-17 1980-11-18
US4150153A (en) * 1977-05-13 1979-04-17 Syntex (U.S.A.) Inc. 1-(Naphthylethyl)imidazole derivatives
US4172896A (en) * 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
IT1097314B (it) * 1978-07-26 1985-08-31 Recordati Chem Pharm Derivati dell'imidazolo ad attivita' anticonvulsivante
US4644064A (en) * 1981-02-25 1987-02-17 Hoechst-Roussel Pharmaceuticals Inc. 1,2-benzisoxazoloxyethylamines and intermediates for the preparation thereof
US4598152A (en) * 1982-04-09 1986-07-01 Hoechst-Roussel Pharmacueticals Inc. 6-fluoro-3-[3-(oxoheterocyclo)propyl]-1,2-benzisoxazoles
ATE67493T1 (de) * 1985-02-04 1991-10-15 Bayer Agrochem Kk Heterocyclische verbindungen.
US4723021A (en) * 1986-08-27 1988-02-02 Pennwalt Corporation Substituted 5-(phenoxyalkyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines

Also Published As

Publication number Publication date
DK379888A (da) 1989-01-09
EP0298921A1 (de) 1989-01-11
ES2053802T3 (es) 1994-08-01
EP0298921B1 (de) 1992-12-23
YU131388A (en) 1990-04-30
PT87919A (pt) 1989-06-30
HUT51271A (en) 1990-04-28
US4859691A (en) 1989-08-22
IL86981A (en) 1993-07-08
MX12167A (es) 1993-12-01
NO883044D0 (no) 1988-07-07
NZ225312A (en) 1991-05-28
JPS6429376A (en) 1989-01-31
IL86981A0 (en) 1988-12-30
HU206343B (en) 1992-10-28
FI883218A0 (fi) 1988-07-06
JPH0569836B2 (el) 1993-10-01
NO170804C (no) 1992-12-09
NO883044L (no) 1989-01-09
MY103571A (en) 1993-08-28
KR890002134A (ko) 1989-04-08
AU1881388A (en) 1989-01-12
AU602594B2 (en) 1990-10-18
PT87919B (pt) 1995-03-01
NO170804B (no) 1992-08-31
ATE83776T1 (de) 1993-01-15
FI883218A (fi) 1989-01-09
GR3007228T3 (el) 1993-07-30
DK379888D0 (da) 1988-07-07
DE3876875D1 (de) 1993-02-04
ZA884879B (en) 1989-01-09

Similar Documents

Publication Publication Date Title
DE60218340T2 (de) 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten
DE602004007808T2 (de) Neue gamma-sekretase-inhibitoren
DE60121590T2 (de) Pyrazolderivate
EP1215210B1 (de) Benzofurane
CH624395A5 (el)
DE3435745C2 (de) 2-[3-[4-(3-Phenyl)-1-piperazinyl]propyl]-2,4-dihydro-3H-1,2,4-triazol-3-on Verbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
CH648553A5 (de) Neue 3,4-dihydro-5h-2,3-benzodiazepin-derivate und verfahren zur herstellung derselben.
EP0243903A1 (de) Gegebenenfalls substituierte, 1-(w[bis-(Phenyl)-alkoxy]-alkyl)-4-(alkenyl)-piperazine und -4-(alkinyl)-piperazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DD273440A5 (de) Verfahren zur herstellung von 1,2 benzisoxazolen und 1,2-benziothiazolen
EP0964863A1 (de) Oxazolidinone als 5-ht2a-antagonisten
EP0282502A1 (de) Imidazol-derivate.
EP0237916A2 (de) 1, 1-Disubstituierte Cyclopropanderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Antimykotika oder als Zwischenprodukte
DE3209304C2 (el)
NL8005491A (nl) Heterocyclische verbindingen met therapeutische wer- king.
DE3900028A1 (de) Gegebenenfalls am phenylrest halogen- und/oder alkyl- und/oder alkoxy- oder methylendioxysubstituierte, 5,5-di-(methyl)-3-(phenylvinyl)-1-(substituiert amino-alkoxy-imino)-cyclohex-2-enderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE4117750A1 (de) Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
WO1992010482A1 (de) Funktionalisierte vinylazole enthaltende pharmazeutische präparate, verwendung dieser vinylazole zur herstellung von arzneimitteln, vinylazole selbst sowie verfahren zu deren herstellung
DE60010855T2 (de) Phenylsulphonylderivative als 5-ht rezeptorliganden
DE2819873C2 (el)
EP0074929A1 (de) Neue polycyclische Polyazaheterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2412520A1 (de) Tricyclische verbindungen
EP0389425A1 (de) Neue Benzothiopyranylamine
CH644364A5 (de) 4-(naphthalinyloxy)piperidin-derivate.
EP0478941B1 (de) Arzneimittel welche substituierte 2-Cyclohexen-1yl-amin-Derivate enthalten und ihre Verwendung zur Bekämpfung von Krankheiten
DE3617190A1 (de) Neue azolderivate, verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee